Martin F. Orth
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.
Journal: Nature
Published: February 07, 2026
The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma.
Journal: NPJ precision oncology
Published: May 30, 2025
High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma.
Journal: The Journal of clinical investigation
Published: October 01, 2024
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.
Journal: Nature
Published: August 30, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma.
Journal: Cell death discovery
Published: January 19, 2022
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions.
Journal: Molecular cell
Published: September 15, 2021
Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma.
Journal: Molecular cancer
Published: September 03, 2021
Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma.
Journal: Molecular cancer
Published: March 19, 2021
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.
Journal: Nature
Published: December 20, 2020
Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer.
Journal: Nature communications
Published: December 03, 2020
Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma.
Journal: Nature communications
Published: November 24, 2020
Last Updated: 09/26/2026